rs1555884864

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 1P and 1B. PM2_SupportingBP4

This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.1197C>G (p.Ser399Arg) is a missense mutation that is not present in gnomAD v2.1.1 and v3.1.2 (PM2_supporting). This variant has a REVEL score < 0.50 (0.126), and a SpliceAI score ≤ 0.20 (0.0) (BP4). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria have been applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PM2_supporting, BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA410147801/MONDO:0011071/008

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

RUNX1
NM_001754.5 missense

Scores

3
7
8

Clinical Significance

Uncertain significance reviewed by expert panel U:3

Conservation

PhyloP100: 2.89

Publications

0 publications found
Variant links:
Genes affected
RUNX1 (HGNC:10471): (RUNX family transcription factor 1) Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
RUNX1 Gene-Disease associations (from GenCC):
  • hereditary thrombocytopenia and hematologic cancer predisposition syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, G2P
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
For more information check the summary or visit ClinGen Evidence Repository.
BP4
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001754.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RUNX1
NM_001754.5
MANE Select
c.1197C>Gp.Ser399Arg
missense
Exon 9 of 9NP_001745.2
RUNX1
NM_001001890.3
c.1116C>Gp.Ser372Arg
missense
Exon 6 of 6NP_001001890.1Q01196-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RUNX1
ENST00000675419.1
MANE Select
c.1197C>Gp.Ser399Arg
missense
Exon 9 of 9ENSP00000501943.1Q01196-8
RUNX1
ENST00000300305.7
TSL:1
c.1197C>Gp.Ser399Arg
missense
Exon 8 of 8ENSP00000300305.3Q01196-8
RUNX1
ENST00000344691.8
TSL:1
c.1116C>Gp.Ser372Arg
missense
Exon 6 of 6ENSP00000340690.4Q01196-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000141
AC:
2
AN:
1414370
Hom.:
0
Cov.:
35
AF XY:
0.00000286
AC XY:
2
AN XY:
699038
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32668
American (AMR)
AF:
0.0000271
AC:
1
AN:
36918
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25290
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37450
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80562
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49566
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5704
European-Non Finnish (NFE)
AF:
9.19e-7
AC:
1
AN:
1087614
Other (OTH)
AF:
0.00
AC:
0
AN:
58598
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome (1)
-
1
-
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 (1)
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.86
BayesDel_addAF
Benign
-0.058
T
BayesDel_noAF
Benign
-0.32
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.48
T
Eigen
Benign
-0.073
Eigen_PC
Benign
-0.015
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.33
D
MetaRNN
Uncertain
0.51
D
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L
PhyloP100
2.9
PrimateAI
Pathogenic
0.82
D
PROVEAN
Uncertain
-2.5
D
REVEL
Benign
0.13
Sift
Uncertain
0.0020
D
Sift4G
Benign
0.087
T
Polyphen
0.88
P
Vest4
0.55
MutPred
0.53
Loss of glycosylation at S372 (P = 0.0183)
MVP
0.48
MPC
0.78
ClinPred
0.89
D
GERP RS
2.2
Varity_R
0.39
gMVP
0.44
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555884864; hg19: chr21-36164678; API